Baxter/Hill-Rom Helux Pro Surgical Light System
View on SAM.gov ↗ Sign in to save
- Type
- Contract
- Notice type
- Sources Sought
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Solicitation #
- 75N98027Q00038SB_PCA-NIA-11810
- Posted
- Nov 16, 2026
- Response due
- Dec 8, 2026
- Archive date
- Dec 23, 2026
- NAICS
- 339112
- PSC
- 6515
- Set-aside
- Small Business Set Aside - Total
- Place of performance
- Brooklyn, MD, 21225, USA
- Contact
- JOHNSON, JOHN R · johnsonjr@mail.nih.gov · 6673125580
- Source
- SAM.gov
Description
The National Institute on Aging (NIA), Intramural Research Program (IRP), operates the Clinical Research Unit (CRU) located at the MedStar Harbor Hospital campus in Baltimore, Maryland. The CRU serves as the primary dedicated clinical facility supporting human longitudinal and translational aging research protocols, including the Baltimore Longitudinal Study of Aging (BLSA), the Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT) study, and specialized clinical trials investigating age-related functional decline and metabolic disorders. A cornerstone of these intramural clinical protocols involves invasive outpatient biopsy procedures—specifically percutaneous skeletal muscle biopsies, subcutaneous adipose tissue biopsies, and dermal skin punch biopsies. These procedures provide vital biospecimens for cellular, molecular, and physiological characterization of human aging. The existing ceiling-mounted surgical lighting system currently deployed in the CRU procedure suite has reached the end of its useful service life (End-of-Life / EOL). The legacy unit is experiencing persistent operational failures. Critical replacement parts are no longer manufactured or supported by the original equipment manufacturer (OEM), rendering the existing unit non-serviceable. Because medical-grade illumination is a non-negotiable safety and operational prerequisite for procedural asepsis, precise anatomical depth perception, tissue differentiation, and hemostasis, the current state presents an unacceptable clinical risk and threatens immediate disruption to approved NIA protocol timelines.